Last breaking news >> Press release

HEXACATH HOME

Bio Active Stents (BAS), coronary stents, vascular stents and balloon catheters

TITAN2 - Hexacath stent Hexacath develops, manufactures and distributes Bio Active Stents and balloon catheters for interventional cardiologists. The Hexacath portfolio of products includes the first BAS (Bio Active Stent) TITAN2 coated with Titanium-Nitride-Oxide and NO-particles (the unique safe alternative to DES - Drug Eluting Stent), the BMS (Bare Metal Stent) Helistent and the PTCA catheter Rafale.


HEXACATH: STENTING AND CORONARY STENT EXPERIENCE

Stent manufacturing Stenting is HEXACATH know-how. HEXACATH, independant company founded in 1994, develops, produces and commercialises innovative vascular therapy products (Bio Active Stents, coronary stents, PTCA catheters, vascular stents, peripheral stents).

Since 1996, HEXACATH has headed an ambitious Research and Development program in collaboration with public laboratories and both French and European private clinics, with the aim of putting together a range of advanced coronary stents.

One site, in Doubs, an area famous for micromechanics, is dedicated to stent production. The other site, near Paris, was started from scratch for the manufacture of balloon catheters, with a team of experienced engineers.

Thanks to excellent research and controlled quality applied to stent and balloon catheters production, HEXACATH is today a priviliged partner to specialist angioplasty teams, in both France and abroad. HEXACATH is a registered ISO 9001 and EN 46001 company.


HEXACATH: STENT WORLDWIDE PRESENCE

Hexacath Stent - Earth map HEXACATH is present worldwide and participates to the main international cardiology and angioplasty congresses. Official HEXACATH distributors will help you to choose the coronary stents or balloon catheters you need and will explain the last innovations of our interventional cardiology products.


HEXACATH REGISTRIES

After the international launch of the TITAN BAS (Bio Active Stent), HEXACATH has set up with the help of various medical teams, post marketing studies in order to further evaluate the use of TITAN BAS (Bio Active Stent) and its unique Titanium-Nitride-Oxide coating in specific indications.